Citadel Advisors’s Exscientia Plc American Depositary Shares EXAI Stock Holding History

Citadel Advisors’s Portfolio EXAI Stock Details EXAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-74,900	Closed	-$366K	–	15687
2024 Q3	$366K	Buy	74,900 +5,000	+7%	+$26.2K	﹤0.01%	8899
2024 Q2	$356K	Buy	69,900 +45,900	+191%	+$226K	﹤0.01%	8784
2024 Q1	$137K	Sell	24,000 -400	-2%	-$2.49K	﹤0.01%	10902
2023 Q4	$156K	Buy	24,400 +12,600	+107%	+$71.4K	﹤0.01%	10320
2023 Q3	$53.3K	Sell	11,800 -4,400	-27%	-$28.4K	﹤0.01%	11685
2023 Q2	$95.9K	Sell	16,200 -3,300	-17%	-$20.2K	﹤0.01%	11006
2023 Q1	$103K	Buy	19,500 +14,400	+282%	+$97.7K	﹤0.01%	11216
2022 Q4	$27.2K	Buy	+5,100	New	+$32.2K	﹤0.01%	12854

Other funds holding EXAI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Citadel Advisors's EXAI Position: Q4 2024 in Review

Citadel Advisors sold out of Exscientia Plc American Depositary Shares (EXAI) in Q4 2024, closing a stake of 60,997 shares — an estimated $298K sold.

Citadel Advisors first reported a position in EXAI in Q1 2022 and held it in 5 quarters. The position peaked at $629K in Q4 2022. 1 fund tracked by Wall St. Rank holds EXAI as of Q4 2024.

Citadel Advisors reported no remaining Exscientia Plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Citadel Advisors sold 60,997 Exscientia Plc American Depositary Shares shares in Q4 2024, an estimated $298K.
Citadel Advisors first reported a position in Exscientia Plc American Depositary Shares in Q1 2022 and held it in 5 quarters.
Citadel Advisors's Exscientia Plc American Depositary Shares position peaked at $629K in Q4 2022.
1 fund tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.